miR-145-5p and miR-203a-5p overcome imatinib resistance in myelogenous leukemic cells through metabolic reprogramming. (2023). Indian Journal of Biochemistry and Biophysics (IJBB), 60(3), 167-176. https://doi.org/10.56042/ijbb.v60i3.66526